Cargando…

RNA sequencing suggests that non‐coding RNAs play a role in the development of acquired haemophilia

Acquired haemophilia (AH) is a rare disorder characterized by bleeding in patients with no personal or family history of coagulation/clotting‐related diseases. This disease occurs when the immune system, by mistake, generates autoantibodies that target FVIII, causing bleeding. Small RNAs from plasma...

Descripción completa

Detalles Bibliográficos
Autores principales: Tigu, Adrian Bogdan, Hotea, Ionut, Drula, Rares, Zimta, Alina‐Andreea, Dirzu, Noemi, Santa, Maria, Constantinescu, Catalin, Dima, Delia, Bergthorsson, Jon Thor, Greiff, Victor, Gulei, Diana, Coriu, Daniel, Serban, Margit, Mahlangu, Johnny, Tomuleasa, Ciprian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315746/
https://www.ncbi.nlm.nih.gov/pubmed/37317065
http://dx.doi.org/10.1111/jcmm.17741
Descripción
Sumario:Acquired haemophilia (AH) is a rare disorder characterized by bleeding in patients with no personal or family history of coagulation/clotting‐related diseases. This disease occurs when the immune system, by mistake, generates autoantibodies that target FVIII, causing bleeding. Small RNAs from plasma collected from AH patients (n = 2), mild classical haemophilia (n = 3), severe classical haemophilia (n = 3) and healthy donors (n = 2), for sequencing by Illumina, NextSeq500. Based on bioinformatic analysis, AH patients were compared to all experimental groups and a significant number of altered transcripts were identified with one transcript being modified compared to all groups at fold change level. The Venn diagram shows that haemoglobin subunit alpha 1 was highlighted to be the common upregulated transcript in AH compared to classical haemophilia and healthy patients. Non‐coding RNAs might play a role in AH pathogenesis; however, due to the rarity of HA, the current study needs to be translated on a larger number of AH samples and classical haemophilia samples to generate more solid data that can confirm our findings.